Paul O'Mahoney

Dr. Paul O'Mahoney

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2023 in Photochemistry and Photobiology
Verified
Journal Article
Open access
OKObaid Kousha
Obaid Kousha
POPaul O'Mahoney
Paul O'Mahoney
RHRobert Hammond
Robert Hammond
KWKenneth Wood
Kenneth Wood
EEEwan Eadie
Ewan Eadie
Far‐UVC, from filtered Krypton‐Chloride lamps, is promising for reducing airborne transmission of disease. While significant research has been undertaken to investigate skin safety of these lamps, less work has been undertaken on eye safety. There is limited data on human eye safety or discomfort from the deployment of this germicidal technology. In this pilot study, immediate and delayed eye discomfort were assessed in a simulated office environment with deployment of Krypton‐Chloride lamps, located on the ceiling and directed downwards into the occupied room. Discomfort was assessed immediately postexposure and several days after exposure using validated, Standard Patient Evaluation Eye Dryness (SPEED) and Ocular Surface Disease Index (OSDI) questionnaires. Our results show no significant eye discomfort or adverse effects from the deployment of Far‐UVC in this simulated office environment, even when lamps were operated continuously with participants receiving head exposures of up to 50 mJ cm−2. In addition, a statistically significant reduction in bacteria and fungi of 52% was observed. Far‐UVC in this simulated office environment did not cause any clinically significant eye discomfort and was effective at reducing pathogens in the room. These results contribute an important step to further investigation of the interaction of Far‐UVC with the human eye.

5 April 2017 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
POPaul O'Mahoney
Paul O'Mahoney
MKM. Khazova
M. Khazova
MHM. Higlett
M. Higlett
TLT. Lister
T. Lister
SIS. Ibbotson
S. Ibbotson
EEEwan Eadie
Ewan Eadie

20 September 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
POPaul O'Mahoney
Paul O'Mahoney
MKmarina khazova
marina khazova
EEEwan Eadie
Ewan Eadie
SISally Ibbotson
Sally Ibbotson
Successful daylight photodynamic therapy (DPDT) relies on the interaction of light, photosensitisers and oxygen. Therefore, the ‘dose’ of light that a patient receives during treatment is a clinically relevant quantity, with a minimum dose for effective treatment recommended in the literature. However, there are many different light measurement methods used in the published literature, which may lead to confusion surrounding reliable and traceable dose measurement in DPDT, and what the most appropriate method of light measurement in DPDT might be. Furthermore, for the majority of practitioners who do not carry out any formal dosimetry and for the patients receiving DPDT, building confidence in the evidence supporting this important treatment option is of key importance. This review seeks to clarify the methodology of DPDT and discusses the literature relating to DPDT dosimetry.

23 June 2021 in Photochemistry and Photobiology
Verified
Journal Article
Open access
PDF file
EEEwan Eadie
Ewan Eadie
POPaul O'Mahoney
Paul O'Mahoney
LFLouise Finlayson
Louise Finlayson
IBIsla Rose Mary Barnard
Isla Rose Mary Barnard
SISally Helen Ibbotson
Sally Helen Ibbotson
KWKenneth Wood
Kenneth Wood
This study aims to investigate, with computer modeling, the DNA damage (assessed by cyclobutane pyrimidine dimer (CPD) formation) from far-ultraviolet C (far-UVC) in comparison with sunlight exposure in both a temperate (Harwell, England) and Mediterranean (Thessaloniki, Greece) climate. The research utilizes the published results from Barnard et al. [Barnard, I.R.M (2020) Photodermatol. Photoimmunol. Photomed. 36, 476–477] to determine the relative CPD yield of unfiltered and filtered far-UVC and sunlight exposure. Under current American Conference of Governmental Industrial Hygienists (ACGIH) exposure limits, 10 min of sunlight at an ultraviolet (UV) Index of 4—typical throughout the day in a temperate climate from Spring to Autumn—produces equivalent numbers of CPD as 700 h of unfiltered far-UVC or more than 30 000 h of filtered far-UVC at the basal layer. At the top of the epidermis, these values are reduced to 30 and 300 h, respectively. In terms of DNA damage induction, as assessed by CPD formation, the risk from sunlight exposure greatly exceeds the risk from far-UVC. However, the photochemistry that will occur in the stratum corneum from absorption of the vast majority of the high-energy far-UVC photons is unknown, as are the consequences.

1 September 2018 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
POPaul O'Mahoney
Paul O'Mahoney
NHNeil Haigh
Neil Haigh
KWKenny Wood
Kenny Wood
CBC. Tom A. Brown
C. Tom A. Brown
SISally Ibbotson
Sally Ibbotson
EEEwan Eadie
Ewan Eadie
Implementation of daylight photodynamic therapy (dPDT) is somewhat limited by variable weather conditions. Light sources have been employed to provide artificial dPDT indoors, with low irradiances and comparable treatment times to dPDT. Uniform light distribution across the target area is desirable in effective treatment planning, particularly for large areas. A novel light source is developed with tuneable direction of light emission in order to meet this challenge. Wavelength composition of the novel light source is controlled such that the protoporphyrin-IX (PpIX) weighted spectra of both the light source and daylight match. The uniformity of the light distribution is characterised on a flat surface, a model head and a model leg. For context, a typical conventional PDT light source is also characterised. Additionally, the wavelength uniformity across the treatment site is characterised. The PpIX-weighted spectrum of the novel light source matches the PpIX-weighted daylight spectrum, with irradiance values within the bounds for effective dPDT. By tuning the direction of light emission, improvements are seen in the uniformity across large anatomical surfaces. Wavelength uniformity is discussed. We have developed a light source that addresses the challenges in uniform, multiwavelength light distribution for large area artificial dPDT across curved anatomical surfaces.

28 March 2019 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
LML.J. McLellan
L.J. McLellan
POPaul O'Mahoney
Paul O'Mahoney
SLS. Logan
S. Logan
SYS. Yule
S. Yule
CGC. Goodman
C. Goodman
EEEwan Eadie
Ewan Eadie
In the UK, almost one in four individuals over 60 are affected by actinic keratoses (AK), and this is a cause of significant morbidity in an ageing population, with risk of progression to squamous cell carcinoma. Daylight photodynamic therapy (dPDT) is an effective and simple treatment for field change AK, with similar efficacy to conventional PDT. Commonly, skin surface preparation is performed in a Dermatology clinic prior to dPDT. However, a recent German study by Karrer and colleagues investigated dPDT as a patient‐applied home‐delivered treatment for face and scalp AK and reported that patients who undertook this self‐administered treatment had high levels of efficacy, tolerance and patient satisfaction.